Bamboos Health Care Holdings Limited (HKG:2293)
Hong Kong · Delayed Price · Currency is HKD 0.4000
0.00 (0.00%)
Oct 7, 2026, 3:16 PM HKT
HKG:2293 Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 66.48 | 74.4 | 94.79 | 126.56 | 140.3 |
Other Revenue | 0.23 | 0.57 | 0.74 | 1.26 | 1.1 |
| 66.71 | 74.97 | 95.53 | 127.81 | 141.4 | |
Revenue Growth | -11.01% | -21.52% | -25.26% | -9.61% | 27.61% |
Cost of Revenue | 37.12 | 34.15 | 36.09 | 50.16 | 50.06 |
Gross Profit | 29.6 | 40.82 | 59.44 | 77.66 | 91.34 |
Selling, General & Admin | 1.18 | 0.57 | 0.37 | 0.53 | 1.17 |
Other Operating Expenses | 6.09 | 8.04 | 7.45 | 7.28 | 8.39 |
Operating Expenses | 16.41 | 17.87 | 17.96 | 17.8 | 17.25 |
Operating Income | 13.19 | 22.96 | 41.48 | 59.86 | 74.09 |
Interest Expense | -2.08 | -3.29 | -2.81 | -1.95 | -0.78 |
Interest & Investment Income | 0.57 | 1.76 | 1.88 | 1.52 | 1.34 |
Currency Exchange Gain (Loss) | -1.96 | 0.77 | 0.95 | -0.91 | -0.92 |
EBT Excluding Unusual Items | 9.71 | 22.19 | 41.5 | 58.52 | 73.73 |
Gain (Loss) on Sale of Investments | -0.28 | 0.24 | -2.27 | -0.11 | -1.57 |
Legal Settlements | - | - | - | 0.26 | - |
Other Unusual Items | - | - | - | - | 0.28 |
Pretax Income | 9.44 | 22.43 | 39.23 | 58.67 | 72.44 |
Income Tax Expense | 3.2 | 4.89 | 8.31 | 11.76 | 13.82 |
Earnings From Continuing Operations | 6.24 | 17.54 | 30.92 | 46.92 | 58.62 |
Net Income | 6.24 | 17.54 | 30.92 | 46.92 | 58.62 |
Net Income to Common | 6.24 | 17.54 | 30.92 | 46.92 | 58.62 |
Net Income Growth | -64.45% | -43.27% | -34.10% | -19.96% | -3.94% |
Shares Outstanding (Basic) | 401 | 400 | 400 | 400 | 400 |
Shares Outstanding (Diluted) | 402 | 401 | 400 | 400 | 400 |
Shares Change | 0.18% | 0.21% | 0.03% | - | - |
EPS (Basic) | 0.02 | 0.04 | 0.08 | 0.12 | 0.15 |
EPS (Diluted) | 0.02 | 0.04 | 0.08 | 0.12 | 0.15 |
EPS Growth | -64.53% | -43.46% | -34.10% | -19.96% | -3.94% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | - | 36.55 | 35.75 | 41.68 | 100.37 |
Free Cash Flow Per Share | - | 0.09 | 0.09 | 0.10 | 0.25 |
Dividend Per Share | 0.025 | 0.040 | 0.075 | 0.075 | 0.075 |
Dividend Growth | -37.50% | -46.67% | 0% | 0% | 200.00% |
Gross Margin | 44.36% | 54.45% | 62.22% | 60.76% | 64.59% |
Operating Margin | 19.77% | 30.62% | 43.42% | 46.83% | 52.40% |
Profit Margin | 9.35% | 23.40% | 32.37% | 36.71% | 41.46% |
Free Cash Flow Margin | - | 48.75% | 37.43% | 32.61% | 70.98% |
EBITDA | 15.3 | 25.06 | 42.97 | 61.18 | 75.32 |
EBITDA Margin | 22.93% | 33.43% | 44.99% | 47.86% | 53.27% |
D&A For EBITDA | 2.11 | 2.11 | 1.49 | 1.32 | 1.23 |
EBIT | 13.19 | 22.96 | 41.48 | 59.86 | 74.09 |
EBIT Margin | 19.77% | 30.62% | 43.42% | 46.83% | 52.40% |
Effective Tax Rate | 33.92% | 21.79% | 21.18% | 20.03% | 19.07% |
Advertising Expenses | 1.07 | 0.54 | 0.34 | 0.41 | 0.99 |